A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Doudna’s UC Berkeley genetics lab (alongside Doudna herself) launched on Tuesday, debuting a platform designed ...
Three years ago, Jennifer Doudna gathered with two postdocs and a fellow biochemist around a circular table on the second floor of UC Berkeley’s Energy Biosciences building, where they ...
The new coronavirus can leave some patients with signs of heart inflammation and injury months after they get sick with Covid-19, even in cases where their illness wasn’t severe, ...
Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to ...
From the images of cloudy chest scans and gasping patients hooked up to ventilators, we’ve been conditioned to think of Covid-19 as a respiratory disease. But it’s not just about the lungs.
Even from ...
Maybe we should think of Covid-19 as a heart disease.
When SARS-CoV-2 virus was added to human heart cells grown in lab dishes, the long muscle fibers that keep hearts ...
Nearly two years after the birth of the first “CRISPR babies” stunned the world, an international group of experts on Thursday warned such human experimentation — in which the DNA ...
It’s still too soon to try to make genetically edited babies because the science isn’t advanced enough to ensure safety, says an international panel of experts who also mapped ...
These tiny, ancient predators do more than cause pandemics.
Host Kenneth Cukier and science editor Geoff Carr investigate how viruses have shaped the world. Evolutionary biologist David Enard explains how ...
The coronavirus pandemic is accelerating the development of CRISPR-based tests for detecting disease — and highlighting how gene-editing tools might one day fight pandemics, one of its discoverers, Jennifer ...
Ask any expectant couple what they hope their baby will be, and one answer is likely to be “healthy.”
But one gene gone awry can imperil a child’s health, causing ...
A new Innovative Genomics Institute study is underway at the University of California, Berkeley to find out whether a saliva test can detect and identify asymptomatic carriers of the ...
With the start of school fast approaching, colleges and universities across the U.S. are rushing to rejigger the higher-education experience for the coronavirus era. Many are seeking ways to ...
Scientists from the University of California, Berkeley, have begun trials of a new spit test for COVID-19 infections developed by the university’s Innovative Genomics Institute.
Since the disease was first ...
California is experiencing a surge in reported cases of COVID-19. Three months into the pandemic tests remain scarce.
Early on, at UC Berkeley, Dr. Jennifer Doudna who co-discovered CRISPR gene editing ...
I have always loved mystery stories. Maybe that explains my fascination with science, which is humanity’s attempt to understand the longest-running mystery we know: the origin and function of ...
Exploring the COVID-19 crisis and the way forward.
Treating a disease that affects people of all ages and health backgrounds in different ways is no simple feat. ABC News’ Diane ...
When a stay-at-home order in March all but closed the revered labs of the gene-editing pioneer Jennifer Doudna, her team at the University of California, Berkeley dropped everything and started testing ...
In his 20 years in and out of homelessness, Ollie Harris, 69, has seen a lot of things. But what happened on a recent Friday was new.
Sitting outside his ...
Increasingly inexpensive genetic sequencing and engineering tools could upend everything from health care to fuel.
Why it matters: This bio revolution could lead to a world that is more sustainable and ...
Clinical trials of genome-editing agents — including CRISPR–Cas9 editors, zinc finger nucleases and TALENs — are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.
Focus
CRISPR
Client
UC Berkeley
READ THE ...
As the new coronavirus has spread from person to person, and country to country, the virus has changed thousands of times. The vast majority of these changes are incremental. ...
In the early 1950s, psychiatrists began treating schizophrenia with a new drug called chlorpromazine. Seven decades later, the drug is still used as an anti-psychotic.
But now scientists have discovered that ...
With all the suffering and anxiety across much of the world, it’s understandably difficult to conjure up how a post-coronavirus world might look. But failure to think past COVID-19 would ...
Paul Laudicina at Kearney’s Global Business Policy Council interviews CRISPR pioneer Dr. Jennifer Doudna who is doing new work to understand and slow the spread of COVID-19.
They discuss the ...
In mid-February, a California woman with chronic health problems tested positive for coronavirus. She hadn’t traveled overseas, nor had she come into contact with anyone who had it.
When Nevan ...
A vaccine for the deadly coronavirus could be years away and the world can’t wait that long. But what if there was a cure that already existed? While big ...
Before the pandemic, there was only a small group of researchers dedicated to studying coronaviruses. Now though, scientists around the world are turning their focus to the virus called SARS-CoV-2.
There’s a ...
A global group of scientists and lawyers announced their efforts to make their intellectual property free for use by others working on coronavirus pandemic relief efforts—and urged others to ...
From the moment the world heard about a novel coronavirus, known now as SARS-CoV-2, causing widespread respiratory illnesses in China, scientists leapt into action.
Academic, government, and industry labs mobilized ...
Jennifer Doudna, biochemist at University of California at Berkeley and CRISPR co-inventor, discusses the partnership between the Innovative Genomic Institute and the university to run rapid response testing during ...
In the manner of academic scientists during normal times, at the end of a day that was light years from normal, Enrique Lin Shiao led with the data.
Never mind ...
Nearly two-thirds of the coronavirus tests conducted in California are still awaiting results – in part due to an initial bottleneck at a single laboratory – leaving medical providers ...
Thousands of researchers around the world are investigating existing drugs as potential therapies for COVID-19, most of them looking at antivirals, such as remdesivir, developed to treat Ebola, or ...
Like many of the first 6.7 million Americans asked to shelter in place, Enrique Lin Shiao was spending more time than usual on Twitter. The molecular biophysicist had moved to ...
A team of scientists, clinicians and volunteers at UC Berkeley has scrounged together a battery of high-tech machinery from various locations and built a pop-up COVID-19 laboratory capable of ...
U.C. Berkeley says by next week their robotics lab should be able to analyze 1,000 novel coronavirus test results in a single day.
This news comes as we continue to ...
The World Health Organization has said that the best way to tackle this virus is to test, test, test. This is a call to action for biochemist and CRISPR ...
A team of academic and industry researchers led by Jennifer Doudna, the researcher best known for her role in the discovery of the gene editing technology called CRISPR, has ...
